Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
Immunomedics Inc (IMMU US)
Watchlist
10
Analysis
Health Care
•
United States
Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
21 Feb 2022 04:02
Insights from Data Mining Technical Publications - Plant Extracts Including from Cannabis
Herbal medicinal and nutraceutical extracts are seen as instruments to maintain health and treat some conditions. Cannabis, in particular, will see...
Pyari Menon
Follow
284 Views
Share
bullish
•
Everest Medicines
•
24 Oct 2020 15:47
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
Kemp Dolliver, CFA
462 Views
Share
bullish
•
Immunomedics Inc
•
30 Sep 2020 20:17
MergerTalk: Gilead Sciences Takeover Of Immunomedics -Still Something In It For The Arbitrageurs
While the jury will be out for a while on the long-term value impact of this particular deal on GILD
Robert Sassoon
Follow
637 Views
Share
bullish
•
Immunomedics Inc
•
30 Sep 2020 09:30
Gilead/Immunomedics: Bosom Buddies
Back in April, The FDA recently approved Trodelvy (sacituzumabgovitecan-hziy), an antibody-drug conjugate (ADC), for the treatment of patients...
David Blennerhassett
Follow
423 Views
Share
bullish
•
Everest Medicines
•
26 Sep 2020 18:40
Everest Medicines IPO Initiation: Potent Medicine
Everest Medicines Everest Medicines (EVEREST HK) is a biopharmaceutical company which targets four therapeutic areas - oncology, immunology,...
Arun George
Follow
493 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x